Rani Therapeutics Holdings, Inc.·4

Aug 8, 4:10 PM ET

McKinley Kate 4

4 · Rani Therapeutics Holdings, Inc. · Filed Aug 8, 2023

Insider Transaction Report

Form 4
Period: 2023-08-07
McKinley Kate
Chief Business Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-05-22+250,000250,000 total
    Exercise: $4.13Exp: 2033-05-21Class A Common Stock (250,000 underlying)
Footnotes (1)
  • [F1]The shares subject to the option vest 25% on May 22, 2024 and 1/48th of the shares subject to the option vest monthly thereafter over the following three years.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION